Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-66.49M
↓ 96% vs avg
Percentile
P15
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-33.96M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-66.49M | +2.9% |
| 2024 | $-68.51M | -150.5% |
| 2023 | $-27.35M | +26.9% |
| 2022 | $-37.44M | +54.4% |
| 2021 | $-82.13M | - |
| 2020 | $0.00 | +100.0% |
| 2019 | $-16.14M | +59.0% |
| 2018 | $-39.31M | -383.0% |
| 2017 | $13.89M | +186.4% |
| 2016 | $-16.08M | - |